L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
1.144
EUR
2.14%
Market Closed
Market Cap:
€215.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
N
|
New York Community Bancorp Inc
F:QC1
|
US |
|
S
|
SoftBank Group Corp
F:SFT
|
JP |
|
T
|
Travelers Companies Inc
DUS:PA9
|
US |
|
I
|
International Flavors & Fragrances Inc
DUS:IFF
|
US |
|
8
|
8x8 Inc
DUS:EGT
|
US |
|
S
|
SeaWorld Entertainment Inc
XBER:W2L
|
US |
|
Woodward Inc
NASDAQ:WWD
|
US |
|
E
|
Energy Recovery Inc
F:5E2
|
US |
|
C
|
Carmax Inc
SWB:XA4
|
US |
|
N
|
National Australia Bank Ltd
OTC:NAUBF
|
AU |
|
Acme United Corp
F:UT1
|
US |
|
I
|
Income Opportunity Realty Investors Inc
AMEX:IOR
|
US |
Multiples-Based Value
The Multiples-Based Value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is hidden EUR. Compared with the current market price of 1.144 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BT3 Multiples-Based Value
LOCKED
